You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
|
|---|---|
| Published in |
The Lancet Diabetes & Endocrinology, August 2021
|
| DOI | 10.1016/s2213-8587(21)00203-5 |
| Pubmed ID | |
| Authors |
Naveed Sattar, Matthew M Y Lee, Søren L Kristensen, Kelley R H Branch, Stefano Del Prato, Nardev S Khurmi, Carolyn S P Lam, Renato D Lopes, John J V McMurray, Richard E Pratley, Julio Rosenstock, Hertzel C Gerstein |
X Demographics
The data shown below were collected from the profiles of 330 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 47 | 14% |
| United States | 44 | 13% |
| United Kingdom | 19 | 6% |
| Canada | 13 | 4% |
| Mexico | 8 | 2% |
| Brazil | 7 | 2% |
| Saudi Arabia | 5 | 2% |
| India | 4 | 1% |
| Denmark | 4 | 1% |
| Other | 39 | 12% |
| Unknown | 140 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 214 | 65% |
| Practitioners (doctors, other healthcare professionals) | 55 | 17% |
| Scientists | 55 | 17% |
| Science communicators (journalists, bloggers, editors) | 6 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 331 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 331 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 34 | 10% |
| Unspecified | 33 | 10% |
| Student > Bachelor | 23 | 7% |
| Other | 22 | 7% |
| Student > Postgraduate | 20 | 6% |
| Other | 67 | 20% |
| Unknown | 132 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 87 | 26% |
| Unspecified | 34 | 10% |
| Biochemistry, Genetics and Molecular Biology | 10 | 3% |
| Nursing and Health Professions | 9 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 3% |
| Other | 39 | 12% |
| Unknown | 143 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 351. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#93,972
of 25,760,414 outputs
Outputs from The Lancet Diabetes & Endocrinology
#99
of 2,163 outputs
Outputs of similar age
#2,764
of 438,855 outputs
Outputs of similar age from The Lancet Diabetes & Endocrinology
#5
of 40 outputs
Altmetric has tracked 25,760,414 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,163 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 75.3. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,855 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.